In a meta-analysis, somatic mutations in the MLH1 and MSH2 genes were found to be prevalent in colorectal cancer, in addition, a higher prevalence of somatic mutations in the MLH1 gene relative to the MSH2 gene was observed in the European group [16]. This evidence concerns the gene MSH2 and colorectal cancer.